Psychiatry

General Hepatology   

Questions discussed in this category


For instance, what do you do when patients have chronic tremors, cognitive impairment, hypertension, etc.?

Is there an absolute cutoff for AST/ALT that you use where the risks outweigh the potential harm reduction benefits of using the medication? &nbs...

This is based on the recent publication by Bernstein et al., PMID 38551564 which investigated the increased rate of initiation of MAUD in the hospital...


Papers discussed in this category


Frontiers in psychiatry, 2018 Oct 08

Pharmacoepidemiology and drug safety, 2018 Sep 25

The Journal of clinical psychiatry, 2020 Aug 04

Scientific reports, 2023 Nov 28

JCI insight, 2023 Jun 22

JHEP reports : innovation in hepatology, 2024 Apr 10